Lipoprotein(a) Concentration in Subclinical Hypothyroidism before and after Levo-Thyroxine Therapy

Endocrine Journal

Volumn 43, Issue 6, 1996, Pages 731-736

  Yildirimkaya, Metin ^a   Özata, Metin ^a   Yilmaz, Kurtuluş ^a   Kilinç, Cumhur ^a   Gündoǧan, M Ali ^a   Kutluay, Türker ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Levo thyroxine therapy; Lipoprotein(a); Subclinical hypothyroidism

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; LIOTHYRONINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; HYPOTHYROIDISM; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0030342489     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.43.731     Document Type: Article

References (32)

1. Helfand M, Crapo LM (1990) Screening for thyroid disease. Ann Intern Med 112: 840-849.
2. Bastenie PA, Vanhaelst L, Bonnyns L, Neve P, Staquet M (1971) Preclinical hypothyroidism: A risk factor for coronary heart disease. Lancet i: 203-204.
3. Dean JW, Fowler PBS (1985) Exaggerated responsiveness to thyrotropin releasing hormone: A risk factor in women with coronary artery disease. Br Med J 290: 1555-1561.
4. Althus BU, Staub JJ, Ryff-De Leche A, Ober Hählein A, Stähelin HB (1988) LDL/HDL - changes in subclinical hypothyroidism: Possible risk factors for coronary heart disease. Clin Endocriol 28: 157-163.
5. Kuusi T, Taskinen MR, Nikkila E (1988) Lipoproteins, lipolytic enzymes and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 66: 51-56.
6. Staels B, Van Tol A, Chan L, Will H, Verhoeven G, Auwerx J (1990) Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase and low density lipoprotein receptor in rats. Endocrinology 127: 1144-1152.
7. Simons K, Ehnholm C, Renknown O, Bloth B (1970) Characterization of the Lp(a) lipoprotein in human plasma. Acta Pathol Microbiol Scand 78: 459-466.
8. Alvarez JJ, Casuncion MA, Olmos JM, Herrera E (1993) Interindividual variation in the partition of lipoprotein (a) into lipoprotein subfractions. Clin Biochem 26: 399-408.
9. Uterman G (1989) The mysteries of Lipoprotein (a). Science 246: 904-910.
10. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G (1990) Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 36: 20-23.
11. Dahlen GH, Guyton JR, Attar M, Farrner JA, Kautz JA, Gotto AM (1986) Association of levels of lipoprotein (a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 74: 758-765.
12. Kostner G, Klein G, Krempler F (1984) Can serum Lp(a) concentration be lowered by drugs and/or diet? In: Carlson LA, Olsson AG (eds) Treatment of Hyperlipoproteinaemics. New York, NY, Raven, pp. 151-156.
13. Gurakar A, Haeg JM, Kostner G, Papadopoulos NM, Brewer HB Jr (1985) Levels of lipoprotein (a) decline with neomycin and niacin treatment. Atherosclerosis 57: 293-301.
14. De Bruin TW, Van Barlingen H, Van Linde Sibenius Trip M, Va Vuurst De Vries AR, Akveld MJ, Erkelens DW (1993) Lipoprotein (a) and apolipoprotein B plasma concentration in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab 76: 121-126.
15. Engler H, Riesen WF (1993) Effect of thyroid function on concentration of lipoprotein (a). Clin Chem 39: 2466-2469.
16. Klausen IC, Nielsen FE, Hegedus L, Gerdes LU, Charles P, Faergeman O (1992) Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein (a). Metabolism 41: 911-914.
17. Spandrio S, Sleiman I, Scalvini T, Salvi A, Di Stefano O, Pagliini R, Baletrieri GP (1993) Lipoprotein (a) in thyroid disfunction before and after treatment. Horm Metab Res 25: 586-589.
18. Pazos F, Alvarez JJ, Rubies-Prat J, Varela C, Lasuncion MA (1995) Long term thyroid replacement therapy and levels of lipoprotein (a) and other lipoproteins. J Clin Endocrinol Metab 80: 562-566.
19. Arem R, Escalante DA, Arem N, Morriset JD, Patsch W (1995) Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein (a). Metabolism 44: 1559-1563.
20. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18: 499-502.
21. Brown CA, Hennessey JV (1989) Clinical significance of mildly elevated thyrotropin levels with normal thyroxine levels. South Med J 82: 681-685.
22. Fowler PBS, Swale J, Andrews H (1970) Hypercholesterolemia in borderline hypothyroidism: Stage of premyxoedema. Lancet 2: 488-491.
23. Glueck CJ, Long J, Tracy T (1991) The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia. Clin Chim Acta 201: 113-122.
24. Kung AW, Pang RW, Janus ED (1995) Elevated serum lipoprotein (a) in subclinical hypothyroidism. Clin Endocrinology 43: 445-449.
25. Arem R, Patsch W (1990) Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Arch Intern Med 150: 2097-2100.
26. Elder J, McLelland A, O'Reilly DSJ, Packard CJ, Series JJ, Sheperd J (1990) The relationship between serum cholesterol and serum thyrotropin, thyroxine and triiodothyronine concentration in suspected hypothyroidism. Ann Clin Biochem 27: 110-113.
27. Bell GM, Todd WTA, Forfor JC, Martyn C, Wathen CG, Gow S, Rieersma R, Toft AD (1989) End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol 22: 83-89.
28. Caron P, Calazel C, Parra HJ, Hoff M, Louvet JP (1990) Decreased HDL cholesterol in subclinical hypothyroidism: The effect of L-thyroxine therapy. Clin Endocrinol 33: 519-523.
29. Klausen IC, Nielsen FE, Hegedus L, Gerdes LU, Charles P, Foergeman O (1992) Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein (a). Metabolism 41: 911-914.
30. Berg K (1991) Genetics of atherogenic lipoprotein (a) and its relation to other atherosclerotic risk factors. Ann Intern Med 15: 209-218.
31. Davidson NO, Carlos RC, Lucaszewicz AM (1990) Apolipoprotein B mRNA editing is modulated by thyroid hormone but not growth hormone administration in the rat. Mol Endocrinol 4: 779-785.
32. Davidson NO, Powell LM, Wallis SC, Scott J (1988) Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J Biol Chem 263: 27: 13482-13485.